Last CNY9.69 CNY
Change Today -0.13 / -1.32%
Volume 4.9M
002099 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

zhejiang hisoar pharm -a (002099) Snapshot

Open
CNY9.86
Previous Close
CNY9.82
Day High
CNY9.89
Day Low
CNY9.60
52 Week High
09/4/14 - CNY11.23
52 Week Low
09/23/13 - CNY5.29
Market Cap
3.1B
Average Volume 10 Days
8.3M
EPS TTM
CNY-0.24
Shares Outstanding
324.5M
EX-Date
05/22/14
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ZHEJIANG HISOAR PHARM -A (002099)

Related News

No related news articles were found.

zhejiang hisoar pharm -a (002099) Related Businessweek News

No Related Businessweek News Found

zhejiang hisoar pharm -a (002099) Details

Zhejiang Hisoar Pharmaceutical Co., Ltd. produces and sells fine chemicals and raw drugs in the China. It provides raw drugs that include antibody, anti-virus, cardiovascular, sugar-reducing, and worm-driven drugs for human and animal; and fine chemicals, such as medicine intermediates and other customized and processed products, as well as active pharmaceutical ingredients. The company also exports its products internationally. Zhejiang Hisoar Pharmaceutical Co., Ltd. is based in Taizhou, China.

zhejiang hisoar pharm -a (002099) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

zhejiang hisoar pharm -a (002099) Key Developments

Zhejiang Hisoar Pharmaceutical Co., Ltd. to Report First Half, 2014 Results on Jul 30, 2014

Zhejiang Hisoar Pharmaceutical Co., Ltd. announced that they will report first half, 2014 results on Jul 30, 2014

Zhejiang Hisoar Pharmaceutical Co., Ltd. Approves Amendments to the Articles of Association

Zhejiang Hisoar Pharmaceutical Co., Ltd. approved amendments to the articles of association of the company at its AGM held on May 15, 2014.

Zhejiang Hisoar Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, May 21, 2014

Zhejiang Hisoar Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, May 21, 2014., at 14:00 China Standard Time. Agenda: To consider eligibility for assets purchase; to consider connected transactions regarding major assets restructuring of assets purchase; to consider transaction concerning regulation of assets restructuring by listed companies; to consider assets restructuring of assets purchase; to consider report on assets purchase; to consider signing of agreement on assets purchase and profit compensation agreement; to consider audit report, profit forecast audit report, pro forma audit report, pro forma profit forecast audit report and assets evaluation report related to assets purchase; to consider statement on compliance and completeness of implementing legal proceedings of restructuring; to consider opinion on independence of evaluation institution; to consider exemption from tender offer obligation to increase shareholding; and to consider authorization to board to handle matters related to major assets restructuring.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002099:CH CNY9.69 CNY -0.13

002099 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002099.
View Industry Companies
 

Industry Analysis

002099

Industry Average

Valuation 002099 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.7x
Price/Book 4.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZHEJIANG HISOAR PHARM -A, please visit www.hisoar.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.